Advertisement
YOU ARE HERE: LAT HomeCollections

In Brief / PHARMACEUTICALS

Wyeth threatens suit against Teva

December 25, 2007|From Times Wire Services

A patent dispute over the heartburn drug Protonix escalated when Wyeth said it would sue to recover lost profit from sales of Teva Pharmaceutical Industries' generic version. The companies are discussing a possible settlement.

Teva has a 180-day period of market exclusivity for being the first company to file for a generic version of Protonix. Teva does not dispute that it infringed Wyeth's patent but argues that the patent itself is not valid.

Advertisement
Los Angeles Times Articles
|
|
|